Literature DB >> 8523461

Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro.

H Luss1, S C Watkins, P D Freeswick, A K Imro, A K Nussler, T R Billiar, R L Simmons, P J del Nido, F X McGowan.   

Abstract

Lipopolysaccharide (LPS) treatment results in widespread expression of the inducible isoform of nitric oxide (NO) synthase (iNOS). Although there is evidence for the expression of iNOS in heart tissue, regulation of myocardial iNOS expression is not known. To determine the time course and degree of iNOS induction in the adult heart, we examined iNOS mRNA expression and enzyme activity in (1) rat left ventricular tissue after LPS treatment in vivo, and (2) cultured, long-term rat cardiac myocytes maintained in serum and exposed to interleukin-1 beta, tumor necrosis factor-alpha, interferon-gamma, and/or LPS. iNOS mRNA was detected by Northern blot analysis and in situ hybridization. iNOS enzyme activity was measured in extracts of whole heart, and nitrate and nitrite (the stable end-products of NO) accumulation was quantified in cardiomyocyte culture media. iNOS mRNA was not detected in untreated hearts or cultured myocytes but was apparent within 3 h in both hearts obtained from LPS-treated animals and in cytokine-treated myocytes. In whole heart, iNOS mRNA expression peaked by 6 h after LPS and declined by 12 and 24 h. In situ hybridization demonstrated perinuclear localization of iNOS mRNA in both cardiac vascular smooth muscle and myocytes with maximal expression at 6 h after LPS injection. In cardiac myocytes, iNOS expression was maximal at 12 to 24 h, persisted through 48 h, and was partially inhibited by dexamethasone. Interferon-gamma was the most potent single cytokine with regards to myocyte iNOS induction. Nitric oxide release in cytokine-stimulated cardiac myocytes was largely in the form of nitrate and was associated with increased glucose uptake and lactate release; the former finding indicates that NO interacts with myocardial heme proteins and/or oxyradicals, while the latter suggests inhibition of oxidative metabolism. Although non-myocardial cells may significantly contribute to iNOS expression in whole heart tissue, significant iNOS expression and NO production also take place within the myocyte. Induced NO production may regulate myocardial perfusion and impair myocardial function and metabolism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8523461     DOI: 10.1016/0022-2828(95)90023-3

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  15 in total

Review 1.  Cardiac dysfunction in sepsis: new theories and clinical implications.

Authors:  R M Grocott-Mason; A M Shah
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

2.  Small dedifferentiated cardiomyocytes bordering on microdomains of fibrosis: evidence for reverse remodeling with assisted recovery.

Authors:  Fahed Al Darazi; Wenyuan Zhao; Tieqiang Zhao; Yao Sun; Tony N Marion; Robert A Ahokas; Syamal K Bhattacharya; Ivan C Gerling; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2014-09       Impact factor: 3.105

3.  Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy.

Authors:  Edecio Cunha-Neto; Victor J Dzau; Paul D Allen; Dimitri Stamatiou; Luiz Benvenutti; M Lourdes Higuchi; Natalia S Koyama; Joao S Silva; Jorge Kalil; Choong-Chin Liew
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

4.  Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning.

Authors:  J Imagawa; D M Yellon; G F Baxter
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Lipopolysaccharide and cytokines inhibit rat cardiomyocyte contractility in vitro.

Authors:  Ion A Hobai; Justin C Morse; Deborah A Siwik; Wilson S Colucci
Journal:  J Surg Res       Date:  2014-09-22       Impact factor: 2.192

6.  Piroxicam reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide.

Authors:  C Kemal Buharalioglu; Belma Korkmaz; Tuba Cuez; Seyhan Sahan-Firat; Ayse Nihal Sari; Kafait U Malik; Bahar Tunctan
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-05-06       Impact factor: 4.080

7.  Contribution of vasoactive eicosanoids and nitric oxide production to the effect of selective cyclooxygenase-2 inhibitor, NS-398, on endotoxin-induced hypotension in rats.

Authors:  Bahar Tunctan; Belma Korkmaz; Tuba Cuez; C Kemal Buharalioglu; Seyhan Sahan-Firat; John Falck; Kafait U Malik
Journal:  Basic Clin Pharmacol Toxicol       Date:  2010-11       Impact factor: 4.080

8.  Systematic evaluation of nitric oxide, tetrahydrobiopterin, and anandamide levels in a porcine model of endotoxemia.

Authors:  Tetsuaki Hashiguchi; Yasuyuki Kakihana; Sumikazu Isowaki; Tamotsu Kuniyoshi; Tatsuya Kaminosono; Etsuro Nagata; Kazumi Tobo; Masamichi Tahara; Naoko Okayama; Yuki Arakawa; Yoshie Kakihara; Tsuyoshi Goromaru; Nobuo Nakanishi; Hiroe Nakazawa; Yuichi Kanmura
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

9.  Cytokines and lipopolysaccharides induce inducible nitric oxide synthase but not enzyme activity in adult rat cardiomyocytes.

Authors:  Jeannette Vásquez-Vivar; Jennifer Whitsett; Irina Ionova; Eugene Konorev; Jacek Zielonka; Balaraman Kalyanaraman; Yang Shi; Galen M Pieper
Journal:  Free Radic Biol Med       Date:  2008-06-27       Impact factor: 7.376

10.  Identification, characterization, and gene expression profiling of endotoxin-induced myocarditis.

Authors:  Ma-Li Wong; Fiona O'Kirwan; Nadia Khan; Jonas Hannestad; Kwok H Wu; David Elashoff; Gregory Lawson; Philip W Gold; Samuel M McCann; Julio Licinio
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.